Our results of ELISA demonstrated that the serum levels of TNF-α, IL-1β and IFN-γ were increased in mice with DSS-induced colitis, but down-regulated after treatment with recombinant IGFBP5. The gene discussed is IGFBP5; the disease is colitis.